Shares of Opgen Inc. (OPGN Stock Report) gapped up

Shares of Opgen Inc. (OPGN Stock Report) gapped up on Friday morning. The company put out a tweet stating that it’s now offering COVID IgG/IgM rapid test kits with a 10-minute turn around time for results. The test was granted Emergency Use Authorization by the FDA according to the company. That’s not the same as FDA approval, however.

The antibody test uses whole blood, serum, or plasma to detect if antibodies are present. This latest spike comes after weeks of sideways trading in the stock. Friday saw shares reach a premarket high of $2.92 so far. Will that trend continue through August?

Twitter has become the go-to for Opgen communications recently. In July the company revealed more developments This included its poster presentation from the American Society for Microbiology’s ASM 2020. As far as upcoming dates to note, we look to next week. On August 12th Opgen is set to report Q2 results and give a business update.

The majority of my post are the top 20% gainer! To decode them its (ticker ID, % Changed, Volume, Close price and Float) I typically put V,C&F as a prefix to that number and use K, M and B as a suffix (Kilo, Million & Billion) for volume and float. I may also use S for Support and R for Resistance.

I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.